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AbSTrACT
Objectives Murine models of interleukin (il)-23-driven 
spondyloarthritis (spa) have demonstrated entheseal 
accumulation of γδT-cells which were responsible for 
the majority of local il-17a production. However, il-23 
blockers are ineffective in axial inflammation in man. This 
study investigated γδT-cell subsets in the normal human 
enthesis to explore the biology of the il-23/17 axis.
Methods Human spinous processes entheseal 
soft tissue (esT) and peri-entheseal bone (PeB) 
were harvested during elective orthopaedic 
procedures. entheseal γδT-cells were evaluated using 
immunohistochemistry and isolated and characterised 
using flow cytometry. rna was isolated from γδT-cell 
subsets and analysed by qPcr. entheseal γδT-cells 
were stimulated with phorbol 12-myristate 13-acetate 
(PMa) and ionomycin, anti-cD3/28 or il-23 and il-17a 
production was measured by high-sensitivity elisa and 
qPcr.
results entheseal γδT-cells were confirmed 
immunohistochemically with Vδ1 and Vδ2 subsets 
that are cytometrically defined. Transcript profiles of 
both cell populations suggested tissue residency and 
immunomodulatory status. entheseal Vδ2 cells expressed 
high relative abundance of il-23/17-associated 
transcripts including il-23r, rorc and ccr6, whereas 
the Vδ1 subset almost completely lacked detectable 
il-23r transcript. Following PMa stimulation il-17a was 
detectable in both Vδ1 and Vδ2 subsets, and following 
cD3/cD28 stimulation both subsets showed il-17a and 
il-17F transcripts with neither transcript being detectable 
in the Vδ1 subset following il-23 stimulation.
Conclusion spinal entheseal Vδ1 and Vδ2 subsets are 
tissue resident cells with inducible il-17a production 
with evidence that the Vδ1 subset does so independently 
of il-23r expression.
InTrOduCTIOn
The spondyloarthropathies (SpA) are a group of 
inflammatory diseases of which ankylosing spon-
dylitis (AS) is often referred to as the prototypic 
member.1 Mechanical strain is likely to be an 
important environmental risk factor2 which may 
interact with various genetic elements to initiate 
disease. Although dysregulation of the inter-
leukin (IL)-23 signalling pathway is accepted as an 
important risk factor for SpA development,3 4 the 
precise mechanism as to how IL-23 drives disease 
has not been elucidated. A crucial role for enthesitis 
in SpA pathogenesis is supported by observations 
in murine models where either TNFα or IL-23/17 
pathway dysregulation leads to inflammation that 
spreads to adjacent synovium and bone.5–8 A poorly 
defined non-conventional population of lympho-
cytes was originally shown to be responsible for this 
murine entheseal pathology.6 It was subsequently 
shown that an entheseal resident population of 
γδT-cells were the primary source of IL-17A conse-
quent to IL-23 overexpression.9
γδT-cells are non-conventional T-cells that express 
the γδ form of the T-cell receptor (TCR) rather than 
the αβ form expressed by most T lymphocytes.10 
In comparison to αβT-cells, γδT-cells have a limited 
repertoire of V gene segment rearrangements and 
are thought to participate more extensively in 
innate immunity and homeostatic processes.10 11 In 
Key messages
What is already known about this subject?
 ► Entheseal resident γδT-cells drive enthesitis in 
an interleukin (IL)-23 overexpression animal 
model of spondyloarthritis (SpA) but very little 
is known about γδT-cells at the human enthesis.
 ► IL-17 but not IL-23 inhibition is effective in the 
treatment of ankylosing spondylitis.
What does this study add?
 ► This study identifies tissue resident populations 
of γδT-cells in the healthy enthesis that have 
transcript expression related to tissue repair 
and immunomodulation and identifies a subset 
of which is able to produce IL-17 independently 
of IL-23R expression.
How might this impact on clinical practice or 
future developments?
 ► First comprehensive evaluation of human 
entheseal γδT-cells, delivering insights into the 
mechanism underlying effective treatment of 
SpA.
 ► Highlights γδT-cells and IL-23 independent IL-17 
production mechanisms as potential targets of 
future therapeutic strategies.
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Figure 1 γδT-cell localisation and phenotyping. Masson’s trichrome 
stained section showing the area of the spine harvested for analysis. 
Outer edges of the spinous process are labelled peri-entheseal bone 
(PEB) and the interspinous ligament labelled entheseal soft tissue 
(EST) (A). Immunohistochemistry showing γδT-cell receptor expression 
in human colon tissue, inset shows high power image (B). Staining is 
absent with omission of the primary antibody (C). Positive staining is 
observed in the border between the EST and the PEB (D) as well as in 
the haematopoietic bone marrow (E) and deeper within the EST (F). 
Inflammatory infiltrate of ruptured Achilles also contains positively 
stained cells (G). Brown colour and arrows indicate regions of positive 
staining.
adults, γδT-cells expressing a Vδ1 domain constitute a minority 
of the blood γδT-cell population and are reported to recognise 
several unconventional MHC superfamily members which may 
present lipids or are stress induced.10 The Vδ2 subsets are by 
contrast the major subsets present in the blood and react to 
pyrophosphate molecules.12 However, both subsets have been 
shown to be capable of producing IL-1713 and mouse studies 
have shown the importance of the IL-17 producing γδT-cells in 
wound healing and osteogenesis.14
Recent studies have pointed to the non-efficacy of anti-IL-23 
therapy for ankylosing spondylitis,10 whereas anti-IL-17A 
therapy is effective in AS.15 16 A potential explanation for this 
surprising finding is that early experimental SpA, but not estab-
lished disease, is dependent on IL-23,17 which points to the 
importance of innate immunity in disease onset. Therefore, this 
study investigated whether the normal human enthesis had resi-
dent entheseal γδT-cells, key cells in innate immune responses 
and focused on the IL-23/17 axis.
MeTHOdS
Participants and samples
Human entheseal soft tissue (EST) and peri-entheseal bone 
(PEB) (figure 1A) were harvested as previousy described18 from 
normal spinous process and interspinous ligament of 34 patients 
(14 men, 25 women, median age 53) undergoing spinal surgery 
at the Leeds General Infirmary for correction of scoliosis or 
spinal decompression of thoracic or lumbar vertebrae. Entheseal 
tissue donors were not known or suspected to have any systemic 
inflammatory condition including SpA.
Blood was collected from 20 patients with SpA (15 men, 5 
women, median age 44) as well as 14 healthy controls (6 men, 8 
women, median age 38). To determine whether γδT-cells might 
be present at sites of enthesis damage, tissue was procured from 
the peri-entheseal rupture site of patients undergoing surgical 
repair of ruptured Achilles’ tendons (n=3). The investigation 
was approved by North West-Greater Manchester West Research 
Ethics Committee and Leeds East Research Ethics Committee. 
Patients gave informed consent in accordance with the declara-
tion of Helsinki.
Immunohistochemistry
Enthesis samples were fixed by incubation in 4% paraformalde-
hyde solution for 24 hours and then decalcified by incubation 
in 0.5 M EDTA solution. Histological sections of decalcified, 
entheseal tissue were stained using the Envision (Dako) immu-
nohistochemistry staining kit. Slides were incubated with anti-
TCRδ antibody (online supplementary table 1), diluted 1:20 
in antibody diluent (Dako) and incubated for 1 hour at room 
temperature. Staining then proceeded as previously described.18
Cell staining prior to sorting and flow cytometry
EST was separated from PEB and both were enzymatically 
digested as previously described,18 following which, erythrocytes 
were removed by incubation in ammonium chloride buffer. Prior 
to incubation with antibodies, cells were incubated in a blocking 
buffer (10% mouse serum and 1% human IgG in PBS) for 15 min 
at room temperature. All antibody incubations were performed 
at room temperature for 15 min (online supplementary table 1). 
Cells were sorted using an Influx (BD) cell sorter directly into 
RNA extraction buffer supplied as a component of the Pico-
Pure RNA isolation kit (Thermo Fisher), which was then used 
throughout for RNA isolation.
For phenotypic characterisation, cells from each subset were 
categorised as naïve (CD45RAhi, CD45ROlo) tissue resident 
memory (CD45RAlo, CD45ROhi, CD69hi, CD103hi, CCR7lo), 
effector memory (CD45RAlo, CD45ROhi, CCR7lo) and central 
memory (CD45RAlo, CD45ROhi, CCR7hi).
Magnetic bead enrichment and stimulation assays
For magnetic bead enrichment, mononuclear cells were isolated 
using Lymphoprep (Axis Shield) and blocked as previously 
described. Cells were incubated with biotinylated antibodies 
for 15 min at room temperature, then incubated with anti-bi-
otin microbeads (Miltenyi) for 15 min at 4°C and isolated by two 
rounds of magnetic separation using MS columns (Miltenyi). For 
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Figure 2 γδT-cell phenotyping in blood and enthesis using flow 
cytometry. γδT-cells were identified based on positive expression of 
CD45 and CD3 and positive expression of the γδT-cell receptor, and then 
subdivided based on the Vδ isoform of the receptor expressed (A). In 
entheseal tissue (n=11), peri-entheseal bone contained a significantly 
higher proportion of the Vδ1 and a lower proportion of the Vδ2 
expressing cells compared with healthy control blood (n=14) (B). There 
was no difference in subset proportion in spondyloarthritis patients 
(n=20) compared with healthy controls (C). Analysis of γδ subsets 
showing naïve, tissue resident memory (TRM), central memory (CM) and 
effector memory phenotypes (EM) (D). *P<0.05.
post-enrichment activation, subsets were stimulated with PMA/
ionomycin as above or with a combination of anti-CD3/CD28 or 
100 ng/mL IL-23 for 48 hours.
Transcript analysis
Transcript analysis was performed by qPCR using the Biomark 
HD gene expression system (Fluidigm). Briefly, cDNA was 
reverse transcribed using reverse transcription master mix (Flui-
digm) and then underwent pre-amplification (18 cycles) using 
a pre-amp master mix (Fluidigm) with a solution containing 
all primer sets. Gene expression was then measured using a 
dynamic array integrated fluidic circuit (Fluidigm), Taqman gene 
expression assays and universal Taqman master mix (both Ther-
mofisher). We focused on genes involved in tissue repair, cyto-
kine signalling and signal transduction, pattern recognition and 
chemokine signalling. A subset of samples were also analysed 
for expression of genes associated with tissue residence (online 
supplementary table 2). Expression of all genes was measured 
relative to HPRT, and qPCR for PMA-induced cytokine expres-
sion was performed using a Quant Studio real-time PCR system 
(Applied Biosystems).
Measurement of IL-17A by high-sensitivity ELISA
The γδ subsets (δ1 and δ2) were isolated as previously 
described. Cells were stimulated with PMA (25 µg/mL) and iono-
mycin (1 µg/mL) for 1 hour in standard culture conditions. The 
supernatant was removed and replaced with fresh media (RPMI 
1640) and the cells were returned to standard culture conditions 
for 24 hours. Cell supernatant was tested for IL-17A protein 
using IL-17A high-sensitivity (0.25–16 pg/mL sensitivity range) 
ELISA (R&D Systems, Minneapolis, Minnesota, USA) according 
to the manufacturer’s protocol.
Statistics
An independent sample Mann-Whitney U test was used to detect 
differences in γδT-cell subset distribution between EST, PEB 
and peripheral blood (PB). The Kruskal-Wallis test was used to 
detect the differences between expression of tissue residency 
associated transcripts and IL-23/IL-17 axis transcripts in γδT-cell 
subsets from EST, PEB and PB. To compare the overall changes 
in transcript abundance between γδT-cells from entheseal tissue 
and PB, all γδT-cell subsets in both EST and PEB were grouped 
together and compared with all γδT-cell subsets in PB and a 
Mann–Whitney U test was used to detect statistical difference. A 
Wilcoxon signed rank test was used to detect statistical difference 
in intracellular cytokine protein expression and a Mann-Whitney 
U test was used to detect changes in cytokine transcript expres-
sion following PMA stimulation. Unless otherwise stated, all box 
plots display median—line, box—IQR and whiskers—range, all 
bar graphs display median—box, whiskers—IQR. All graphs 
were generated using Prism V.7 (GraphPad), and all statistical 
tests were performed using SPSS V.21 (IBM).
reSulTS
Immunohistochemistry
Positive staining for the γδ TCR was observed in control human 
colon tissue in the stromal compartment (figure 1B), and γδT-cells 
were rare as is consistent with previously published research.19 
The negative control (omission of the primary antibody) 
showed a total lack of positive staining (figure 1C). γδT-cells 
were observed in entheseal tissue at the bone/soft tissue border 
(figure 1D) as well as in the PEB anchoring region haematopoi-
etic bone marrow (figure 1E) and in the soft tissue of the liga-
ment (figure 1F). γδT-cells were also observed in inflammatory 
infiltrate in ruptured Achilles tissue, also indicating their pres-
ence at the sites of injury (figure 1G).
Phenotypic characterisation
For flow cytometry analysis, live cells were discriminated based 
on 7-aminoactinomycin D (7-AAD) exclusion. T-cells were 
selected based on positive expression of CD45 and CD3 with 
a pan-γδ TCR antibody used in combination with Vδ1 and Vδ2 
isoform-specific antibodies identified Vδ1+, Vδ2+ and Vδ3–6 
(Vδ1,Vδ2 double negative) γδT-cell subsets (figure 2A). Healthy 
EST (n=11) contained a similar proportion of γδ subsets (37% 
Vδ1% and 57% Vδ2) as was observed in peripheral blood 
(n=14) (22% Vδ1% and 67% Vδ2). PEB contained a higher 
proportion of the Vδ1 subset and a lower proportion of the 
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Figure 3 γδT-cells in enthesis and blood are transcriptionally distinct. 
Unmatched entheseal tissue derived subsets were compared with 
healthy blood derived cells. They had significantly higher expression of 
transforming growth factor β1 (TGFβ1), nuclear receptor subfamily 4 
group a member 1 (Nr4a1) and lower expression of Krupple-like factor 
2 (KLF2) and T-box 21 (TBX21) (A). All γδT-cell subsets expressed high 
levels of signal transduction molecules and immunomodulatory genes, 
Expression of IL-23/IL-17 axis cytokines was low or absent. Colour 
denotes relative expression to HPRT blue-low, black-equal, yellow-high, 
grey-below detection, Arrows indicate higher expression in γδT-cells 
(all subsets) from entheseal tissue (EST and PEB) compared with blood. 
Numbers show difference in median relative abundance. The ‘un-sorted’ 
category represents gene expression in an unsorted mixture of all cells 
released from entheseal digests (B) (PEB n=12, EST n=12, PB n=6). 
*P<0.05, **P<0.01. EST, entheseal soft tissue; PEB, peri-entheseal bone.
Vδ2 subset (49% and 34%, p=0.031 and 0.027, respectively). 
The proportion of γδT-cells which were Vδ1, Vδ2 double nega-
tive was consistently low (~7%) with no significant difference 
observed between groups (figure 2B). Blood from patients with 
PsA or AS (n=20) showed no difference in the proportion of 
each subset compared with healthy controls (figure 2C). Simi-
larly no significant difference was observed in patients’ blood 
with active disease compared with those in remission (data not 
shown).
Additional phenotypic characterisation for markers of naïve 
and memory T-cell subsets showed differences between γδT-cell 
subsets and changes associated with tissue origin. The Vδ1 subset 
had a far greater proportion of cells with a naïve phenotype 
compared with the Vδ2 irrespective of tissue origin (p=0.001) 
and the Vδ1 subset from PEB contained a greater proportion 
of the tissue resident memory phenotype compared those from 
blood (p=0.43) (figure 2D).
Transcriptional profile for tissue residency and 
immunomodulatory status
Analysis of transcripts associated with tissue residency showed 
significantly increased expression in entheseal derived Vδ1, 
Vδ2 and Vδ3–6 subsets (n=12) compared with those derived 
from peripheral blood (n=6). TGFβ1 was increased on average 
5.4-fold (p=0.010, 0.012 and 0.014, respectively) and NR4A1, 
7.4-fold (p=0.005, 0.016 and 0.041, respectively).20 This 
pattern was reversed in genes with reported lower expression 
in tissue resident T-cells,20 with lower expression in enthe-
seal derived Vδ1, Vδ2 and Vδ3–6 subsets of KLF2, 533-fold 
(p=0.004, 0.034 and 0.009, respectively) and TBX21 6.9-fold 
(p=0.036 and 0.011, respectively) although in this case only in 
entheseal derived Vδ1 and Vδ2 subsets (figure 3A).
Transcriptional analysis of all γδT-cell subsets derived from 
entheseal tissue (n=12) compared with those derived from blood 
(n=6) showed increased expression of growth factor transcripts 
including BMP-2 and VEGFA (p=0.008 and <0.001), as well 
as immunomodulatory factors including IL-10, TGFβ and aryl 
hydrocarbon receptor (AHR) (all p<0.001). All subsets strongly 
expressed JAK/STAT signal transduction genes and had little or 
undetectable expression of IL-17A, IL-17F and IL-22 (Figure 3B 
and online supplementary figure 1).
Different IL-23/17 axis transcriptional profile between Vδ1 and Vδ2 
cells
STAT3 expression was significantly increased in Vδ1, and Vδ3–6 
tissue derived subsets in comparison with age matched blood 
(both p=0.003) with a strong trend were observed in the Vδ2 
subset (p=0.065, figure 4A). Expression of RORC, IL-23R and 
CCR6 (figure 4B–D) was consistently higher in the Vδ2 subset 
compared with Vδ1. Although loss of detectable expression 
in low expressing subsets rendered statistical analysis prob-
lematic, significance was achieved in CCR6 expression in PEB 
(p=0.004). IL-23R expression was consistently detected in the 
Vδ2 subset but was largely absent in entheseal derived Vδ1 and 
Vδ3–6 subsets. IL-23R transcript was detected at a low level in 
1 of 12 samples in each case in EST and in one sample in the 
Vδ3–6 subset in PEB (figure 4C).
Il-17 production in γδT-cell subsets
Next, the ability of entheseal γδT-cell subsets to produce the 
pro-inflammatory cytokines IL-17A, IL-17F, IL-22 and TNFα 
was assessed using ELISA and qPCR. In PMA and ionomycin 
stimulated γδT-cell subsets, TNFα transcript expression was 
significantly increased in Vδ1 and Vδ2 subsets (p=0.001 0.002, 
respectively) (figure 5A). IL-17A was not detected without stim-
ulation but was detected following stimulation (figure 5A) in 
both Vδ1 and Vδ2 subsets. Additionally, high-sensitivity ELISA 
confirmed an increase in IL-17A production in both subsets on 
PMA/ionomycin stimulation in the Vδ1 fraction, the mean basal 
level was 0.70 pg/mL and this rose to 1.60 pg/mL (2.28-fold). In 
the Vδ2 fraction, basal level was 15.56 pg/mL and this rose to 
23.30 pg/mL (1.49-fold) (figure 5B). However, the low number 
of cells made accurate determination of cell number problem-
atic, therefore although the number of input cells used in stim-
ulated and unstimulated conditions was comparable within 
subsets, caution should be used in comparing IL-17A concentra-
tions between Vδ subsets.
Next we assessed the impact of more physiological stimuli 
on both Vδ1 and Vδ2 subsets expression of IL-17A, IL-17F and 
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Figure 5 TNFα and IL-17A are produced by both γδT-cell subsets 
quantitative PCR showing TNFα and IL-17A transcript expression in 
γδT-cell subsets with or without stimulation (n=8) (A). Fold induction of 
secreted IL-17A protein following PMA/ionomycin stimulation compared 
with unstimulated fraction of purified Vδ1 and Vδ2 subsets (n=3) bar 
shows that mean whiskers represent 1 SD (B). Transcript expression of 
IL-17A, IL-17F and IL-22 following 48-hour stimulation of Vδ1 and Vδ2 
subsets with combined anti-CD3/CD28 or IL-23 stimulation (n=10). Line 
denotes mean expression (all genes combined) (C). Genes for which a 
housekeeping value was obtained, but for which a target value was not, 
were assigned a value of 0.0001, as 0 cannot be plotted on a log scale. 
*P<0.05, **P<0.01, ***P≤0.001.
Figure 4 The Vδ2 subset expressed higher levels of genes involved or 
associated with IL-23-driven IL-17 signalling. Entheseal tissue derived 
subsets had generally higher expression of STAT3 compared with blood 
(A) and the Vδ2 subset had the highest expression of RORC (B), IL-23R 
(C) and CCR6 transcript (D) (PEB n=12, EST n=12, PB n=6). *P<0.05, 
**P<0.01. EST, entheseal soft tissue; PEB, peri-entheseal bone.
IL-22 cytokine transcripts. Following stimulation with a combi-
nation of anti-CD3/CD28, robust detection of IL-17A, IL-17F 
and IL-22 transcripts was observed in Vδ1 and Vδ2 subsets 
(figure 5C). In contrast, IL-23 stimulation had almost no effect 
in the Vδ1 subset but caused a marked increase in the Vδ2 subset 
(figure 5C). Finally, we ascertained whether this equated with 
measurable IL-17A protein detection using the highly sensitive 
ELISA. Unlike PMA stimulation, we could not detect changes 
in IL-17A protein using either CD3/CD28 or IL-23 stimulation 
(online supplementary file 5)).
dISCuSSIOn
The γδT-cell population is responsible for the majority of the 
IL-17A produced at the enthesis in IL-23 dependent murine 
models of SpA.6 9 Herein, we describe γδT-cell populations at 
the normal and injured human enthesis by immunohistochem-
istry and flow cytometry and provide evidence supporting their 
entheseal residency. We defined both Vδ1 and Vδ2 entheseal 
resident cells but only Vδ2 subset consistently expressed high 
levels of transcripts associated with IL-17/IL-23 axis cytokine 
signalling, namely RORC, IL-23R and CCR6.21 To the best of 
our knowledge, this is the first description of enthesis resident 
γδT-cells in man and fits in with the knowledge of their role in 
skin and gut disease in general and other recent studies from 
peripheral blood and synovial fluid in spondyloarthritis pointing 
to a key role in disease.22
Following PMA stimulation, IL-17A production was also 
detected in both the Vδ1 and Vδ2 populations by high-sensitivity 
ELISA and this was confirmed by qPCR. Furthermore, qPCR on 
both subpopulations stimulated with anti-CD3/CD28 or IL-23 
confirmed that IL-17A, IL-17F and IL-22 production could be 
driven in the absence of IL-23 and supports the assertion that 
the Vδ1 subset do not express IL-23R under basal conditions 
in entheseal tissue. Since IL-23R transcript expression was 
absent in 11 of 12 Vδ1 subset isolates, this suggests a potential 
for this population to produce IL-17A in an IL-23 independent 
manner. We demonstrated IL-17A protein production in both 
populations using PMA/ionomycin although this is a non-phys-
iological stimulus. Nevertheless, PMA been used extensively to 
demonstrate the functional characteristics of cells although we 
acknowledge that the potential functional drives in vivo in man 
need to be defined.
Also, in the present work, we noted low level IL-23R tran-
script expression in the peripheral blood Vδ1 subset. It has 
also been previously shown that IL-23R expression is upregu-
lated following anti-CD3/CD28 stimulation of Th17 -cells, thus 
meaning any potential IL-17 secretion independent of IL-23 
is hard to prove in the current setting.23 This highlights the 
potential plasticity of these cells and may explain differences 
observed between circulating and entheseal resident γδT-cells. 
It also suggests that IL-23 cannot be excluded from driving 
IL-17A, IL-17F and IL-22 production in these cells in the disease 
environment.
A lower proportion of the Vδ2 subset was observed in enthe-
seal tissue compared with blood suggesting potential enrichment 
of a tissue homing phenotype, since γδT-cells are known to 
migrate and reside in tissues based on specific isoform expres-
sion.11 Alternatively, this may represent the expansion of a resi-
dent population. We did not observe a change in the distribution 
of subsets in the blood of SpA patients where the subset distribu-
tion was similar to healthy controls (figure 2). Analysis of enthe-
seal γδT-cell transcripts that have been suggested to correlate 
with tissue localisation of T-cells in general20 showed clear 
disparities from those isolated from blood. TGFβ1 and NR4A1 
(nuclear hormone receptor NUR/77) were more highly expressed 
in entheseal γδT-cell subsets compared with those isolated from 
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blood. The expression of KLF2 (Krupple-like factor 2) was 
more than two orders of magnitude lower in entheseal derived 
cells, similarly TBX21 (T-bet) expression was greater in Vδ1 and 
Vδ2 subsets but interestingly not in the Vδ3–6 subsets perhaps 
reflecting a stronger Th1-like phenotype in these cells.24 The 
modulation of these genes on tissue residence has largely been 
elucidated in the context of conventional T-cells.25–28 However, 
the striking changes observed in this study suggest that these 
findings can be applied more broadly, including to γδT-cells and 
add additional verification that the γδT-cells derived from enthe-
seal tissues are a distinct tissue resident population.
Further transcriptome analysis showed increased expression 
of genes relevant to bone repair including BMP-229 and angio-
genesis, VEGFA30 in entheseal γδT-cell populations compared 
with those isolated from blood. IL-17A, IL-17F and IL-22 are 
expressed at low levels or absent and cytokines associated with 
an immunomodulatory phenotype, TGFβ and IL-1031 32 are 
increased in entheseal cells. Following in vitro activation of these 
cells TNFα and IL-17A protein were readily detectable.
It has previously been shown that the γδT-cells produced 
IL-17A in the absence of IL-23R. The importance of IL-23 inde-
pendent IL-17 production was first highlighted in the colon 
where inhibition of IL-17A but not IL-23 led to loss of barrier 
integrity, an effect that was attributed to IL-23 independent 
IL-17A production in γδT-cells.33 Analogous to this study, this 
work suggests that IL-17A protein expression can occur inde-
pendently of IL-23 in spinal derived tissue. However, the in vivo 
basis for this in axial SpA remains conjectural but could involve 
activation of different pattern recognition receptors at entheses 
which needs further exploration. Noting that there is evidence 
for IL-23 inhibition efficacy in peripheral psoriatic arthritis,34 35 
the putative differences between spinal and peripheral entheses 
that might underscore this observation need exploration.
Given the recent reports that IL-17A inhibition works in AS 
but IL-23 inhibition does not,15 36 these findings point towards 
a potential IL-23 independent innate immune pathway that may 
provide insights into understanding the clinical scenario. Indeed, 
the demonstration that IL-23 plays a role in innate (disease initi-
ation) but not adaptive immunity in experimental SpA supports 
this view.17 Further studies looking at peripheral entheses and 
entheseal spinal or sacroiliac tissue from active SpA are needed. 
However, these findings highlight a potentially pivotal role for 
γδT-cells in spinal innate immunity in SpA.
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